Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription.

Authors: Cho, IS  Jung, M  Kwon, KS  Moon, E  Cho, JH  Yoon, KH  Kim, JW  Lee, YD  Kim, SS  Suh-Kim, H 
Citation: Cho IS, etal., PLoS One. 2012;7(4):e34860. doi: 10.1371/journal.pone.0034860. Epub 2012 Apr 3.
Pubmed: (View Article at PubMed) PMID:22509362
DOI: Full-text: DOI:10.1371/journal.pone.0034860

CREB mediates the transcriptional effects of glucose and incretin hormones in insulin-target cells and insulin-producing beta-cells. Although the inhibition of CREB activity is known to decrease the beta-cell mass, it is still unknown what factors inversely alter the CREB signaling pathway in beta-cells. Here, we show that beta-cell dysfunctions occurring in chronic hyperglycemia are not caused by simple inhibition of CREB activity but rather by the persistent activation of CREB due to decreases in protein phophatase PP2A. When freshly isolated rat pancreatic islets were chronically exposed to 25 mM (high) glucose, the PP2A activity was reduced with a concomitant increase in active pCREB. Brief challenges with 15 mM glucose or 30 microM forskolin after 2 hour fasting further increased the level of pCREB and consequently induced the persistent expression of ICER. The excessively produced ICER was sufficient to repress the transcription of NeuroD, insulin, and SUR1 genes. In contrast, when islets were grown in 5 mM (low) glucose, CREB was transiently activated in response to glucose or forskolin stimuli. Thus, ICER expression was transient and insufficient to repress those target genes. Importantly, overexpression of PP2A reversed the adverse effects of chronic hyperglycemia and successfully restored the transient activation of CREB and ICER. Conversely, depletion of PP2A with siRNA was sufficient to disrupt the negative feedback regulation of CREB and induce hyperglycemic phenotypes even under low glucose conditions. Our findings suggest that the failure of the negative feedback regulation of CREB is the primary cause for beta-cell dysfunctions under conditions of pathogenic hyperglycemia, and PP2A can be a novel target for future therapies aiming to protect beta-cells mass in the late transitional phase of non-insulin dependent type 2 diabetes (NIDDM).


Gene Ontology Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 8693666
Created: 2014-07-17
Species: All species
Last Modified: 2014-07-17
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.